2019 American Transplant Congress
Orthotopic Liver Transplantation in MPV17 Deficiency: A Case Series
*Purpose: The purpose of this study was to consider the clinical courses of two patients with MPV17 mutations and to evaluate the efficacy of liver…2019 American Transplant Congress
HuR Dictates HO-1 Expression, Modulates Inflammation and Influences Recipient Outcomes in Liver Transplant Patients
Dumont-UCLA Transplant Center, UCLA, Los Angeles, CA
*Purpose: Liver ischemia-reperfusion injury, an innate-immune dominated hepatocellular damage, is a risk factor of early graft dysfunction and rejection in liver transplantation (LT). HuR, an…2019 American Transplant Congress
Management of Dyslipidemia after Liver Transplantation
*Purpose: Cardiovascular disease (CVD) remains a major cause of long-term mortality in liver transplant recipients (LTR). Adequate control of CVD risk factors like hypertension, diabetes,…2019 American Transplant Congress
Novel Cell-Free and Concentrated Ascites Reinfusion Therapy for Management of Refractory Ascites in Liver Transplant Candidates
Department of Gastroenterological and Transplant Surgery, Hiroshima University, Hiroshima, Japan
*Purpose: Refractory ascites at perioperative period in liver transplantation (LT) is associated with the increased morbidity and mortality. The aim of this study is to…2019 American Transplant Congress
Geographic Disparities in Liver Supply/Demand Ratio within Fixed-Distance and Fixed-Person Circles
1JHU, Baltimore, MD, 2USNA, Baltimore, MD
*Purpose: Geographic disparity in deceased donor liver allocation has been extensively documented. Many stakeholders believe allocating within circular fixed-distance or fixed-person boundaries would reduce geographic…2019 American Transplant Congress
Repeat Liver Transplantation after Failed First Transplant in Childhood: Development of a Retransplant Risk Index
*Purpose: Most morbidity and mortality after pediatric liver retransplantation (LRTx) occurs in the first 100 days. We studied factors associated with mortality and graft failure…2019 American Transplant Congress
QA of MMR/VZV Protocol-Driven Serologic Screening and Infectious Disease Consultation (IDC) Are Strongly Recommended in Heart, Lung, Liver (HLL) SOTs
*Purpose: SOT recipients are at risk of acquiring life-threatening infections putting their graft and life at risk. Prevention, including immunization with live virus vaccines pre-transplantation…2019 American Transplant Congress
Assessing the Effectiveness of Early Maintenance Immunosuppression Practices in Liver Transplantation
University of Pennsylvania, Philadelphia, PA
*Purpose: Evidence regarding the efficacy of maintenance immunosuppression (IS) regimens for liver transplantation (LT) arise from clinical trials. However, the ‘real world’ effectiveness of such…2019 American Transplant Congress
Assessing Discarded Human Liver Quality with Normothermic Ex-Vivo Liver Perfusion
Surgery, Washington University in St. Louis, St. Louis, MO
*Purpose: Normothermic Ex-vivo Liver Perfusion (NELP) of livers shows promising results in overcoming injuries that occur in deceased donor liver transplantation. The effect of NELP…2019 American Transplant Congress
Development and Validation of a Capillary Blood Mitra-Based Assay for the Quantitative Determination of Advagraf® Concentrations in Transplant Patients
*Purpose: Therapeutic drug monitoring of tacrolimus (TAC) requires venepuncture blood samples taken by specialists, requiring patients to attend an outpatient clinic; this can be inconvenient…
- « Previous Page
- 1
- …
- 80
- 81
- 82
- 83
- 84
- …
- 180
- Next Page »